{"nct_id":"NCT03272347","title":"Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)","status":"COMPLETED","status_verified_date":"2023-02","start_date":"2017-11-27","start_date_type":"ACTUAL","primary_completion_date":"2021-03-08","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}